PHARMA CROOKS ???
- Thread starter Anonymous
- Start date
-
- Tags
- None
POISON PILLS: The Untold Story of the Vioxx Drug Scandal .
By Tom Nesi
Abruptly taken off the market in September 2004, Vioxx initially seemed like a miracle to the millions suffering from chronic pain and arthritis. Drawing on internal documents, video footage, court testimony, and exclusive interviews, the author tells the dramatic story of what the drug's maker, Merck, knew and when.
The Respected FDA ! There's always ONE JERK in every organization!
FDA Chemist Liang Sentenced to Five Years Prison in Insider-Trading Case (Pazdur should join him)
By Tom Schoenberg - Mar 5, 2012 6:20 PM ET
A U.S. Food and Drug Administration chemist was sentenced to five years in prison for using his access to the agency’s drug-approval process to make $3.78 million in an insider-trading scheme.
Cheng Yi Liang, who worked for the FDA’s Center for Drug Evaluation and Research, was sentenced today by U.S. District Judge Deborah Chasanow in Greenbelt, Maryland, after pleading guilty last year to one count of securities fraud and one count of making false statements.
Liang, 58, was also ordered to forfeit more than $3.7 million. The government sought a sentence at the “high end” of the guidelines’ range of 57 to 71 months, claiming that Liang’s “insider trading conduct” falls within the top 14 percent of insider trading cases filed between 2006 and 2010, according to court papers.
“Cheng Yi Liang bought and sold stocks based on non-public information, and he tried to conceal his crimes by using the names of friends and relatives,” U.S. Attorney Rod J. Rosenstein said in an e-mailed statement. “Mr. Liang violated his duty of loyalty to the FDA and profited from inside information.”
From July 2006 to March 2011, Liang bought and sold stock in more than 25 companies based on inside information from the FDA, according to a charging document.
As part of his plea, Liang agreed to forfeit more than $3.7 million in bank and brokerage accounts and property, including his home in Gaithersburg, Maryland. Liang resigned from the FDA on Sept. 9.
‘Deeply Sorry’
About $1 million of the forfeited funds have already been recovered, Liang’s lawyer, Joseph Evans, said in an e-mail.
“Dr. Liang is deeply sorry for his misconduct,” said Evans, an assistant federal public defender. “Along with the shame that he has brought to his family and friends, he feels especially bad for the FDA for whom he had worked for so many years. He also understands that his actions harmed the United States of America which took him in and permitted him to become a citizen.”
Liang, an FDA employee since 1996, worked in the drug evaluation unit since at least 2001. He had access to nonpublic records of the review process for each drug examined by the office, Assistant U.S. Attorney David Salem said during Liang’s Oct. 18 plea hearing.
$1 Million Gain
The Securities and Exchange Commission, in a parallel civil lawsuit also in Greenbelt, said Liang traded in smaller developmental drug companies, whose stock prices would be more likely to be affected significantly by government decisions. He gained more than $1 million trading stock of Vanda Pharmaceuticals Inc. (VNDA), a Rockville, Maryland, firm that rose more than sevenfold a day after the FDA cleared sales of its schizophrenia drug Fanapt in May 2009, according to the lawsuit.
He profited from share purchases ahead of 19 positive announcements and on short sales before six negative decisions, the SEC said. He also avoided losses by selling stock before two other negative decisions, the agency said. His average profit on each announcement was $135,015, according to the lawsuit.
Liang settled the SEC case in November.
Liang made the trades using his home computer or an Apple iPad, according to the plea agreement.
He made about $380,000 in advance of a Jan. 21 announcement that Newton, Massachusetts-based Clinical Data Inc. (CLDA) ’s Viibryd, a drug to treat a depressive disorder, had been approved, prosecutors said.
Initial Charges
Liang and his son Andrew were initially charged in March 2011 with conspiracy, wire fraud and securities fraud.
Andrew Liang was sentenced to one year in prison after pleading guilty to possession of child pornography found in the course of the fraud investigation. He must also register as a sex offender.
The securities case against Andrew Liang was dismissed at the request of prosecutors.
The cases are U.S. v. Chen Yi Liang, 11-cr-0530, and U.S. v. Andrew Liang, 11-cr-00501, U.S. District Court, District of Maryland (Greenbelt).
FDA Chemist Liang Sentenced to Five Years Prison in Insider-Trading Case (Pazdur should join him)
By Tom Schoenberg - Mar 5, 2012 6:20 PM ET
A U.S. Food and Drug Administration chemist was sentenced to five years in prison for using his access to the agency’s drug-approval process to make $3.78 million in an insider-trading scheme.
Cheng Yi Liang, who worked for the FDA’s Center for Drug Evaluation and Research, was sentenced today by U.S. District Judge Deborah Chasanow in Greenbelt, Maryland, after pleading guilty last year to one count of securities fraud and one count of making false statements.
Liang, 58, was also ordered to forfeit more than $3.7 million. The government sought a sentence at the “high end” of the guidelines’ range of 57 to 71 months, claiming that Liang’s “insider trading conduct” falls within the top 14 percent of insider trading cases filed between 2006 and 2010, according to court papers.
“Cheng Yi Liang bought and sold stocks based on non-public information, and he tried to conceal his crimes by using the names of friends and relatives,” U.S. Attorney Rod J. Rosenstein said in an e-mailed statement. “Mr. Liang violated his duty of loyalty to the FDA and profited from inside information.”
From July 2006 to March 2011, Liang bought and sold stock in more than 25 companies based on inside information from the FDA, according to a charging document.
As part of his plea, Liang agreed to forfeit more than $3.7 million in bank and brokerage accounts and property, including his home in Gaithersburg, Maryland. Liang resigned from the FDA on Sept. 9.
‘Deeply Sorry’
About $1 million of the forfeited funds have already been recovered, Liang’s lawyer, Joseph Evans, said in an e-mail.
“Dr. Liang is deeply sorry for his misconduct,” said Evans, an assistant federal public defender. “Along with the shame that he has brought to his family and friends, he feels especially bad for the FDA for whom he had worked for so many years. He also understands that his actions harmed the United States of America which took him in and permitted him to become a citizen.”
Liang, an FDA employee since 1996, worked in the drug evaluation unit since at least 2001. He had access to nonpublic records of the review process for each drug examined by the office, Assistant U.S. Attorney David Salem said during Liang’s Oct. 18 plea hearing.
$1 Million Gain
The Securities and Exchange Commission, in a parallel civil lawsuit also in Greenbelt, said Liang traded in smaller developmental drug companies, whose stock prices would be more likely to be affected significantly by government decisions. He gained more than $1 million trading stock of Vanda Pharmaceuticals Inc. (VNDA), a Rockville, Maryland, firm that rose more than sevenfold a day after the FDA cleared sales of its schizophrenia drug Fanapt in May 2009, according to the lawsuit.
He profited from share purchases ahead of 19 positive announcements and on short sales before six negative decisions, the SEC said. He also avoided losses by selling stock before two other negative decisions, the agency said. His average profit on each announcement was $135,015, according to the lawsuit.
Liang settled the SEC case in November.
Liang made the trades using his home computer or an Apple iPad, according to the plea agreement.
He made about $380,000 in advance of a Jan. 21 announcement that Newton, Massachusetts-based Clinical Data Inc. (CLDA) ’s Viibryd, a drug to treat a depressive disorder, had been approved, prosecutors said.
Initial Charges
Liang and his son Andrew were initially charged in March 2011 with conspiracy, wire fraud and securities fraud.
Andrew Liang was sentenced to one year in prison after pleading guilty to possession of child pornography found in the course of the fraud investigation. He must also register as a sex offender.
The securities case against Andrew Liang was dismissed at the request of prosecutors.
The cases are U.S. v. Chen Yi Liang, 11-cr-0530, and U.S. v. Andrew Liang, 11-cr-00501, U.S. District Court, District of Maryland (Greenbelt).
Pfizzer crooks again-does this surprise you as they have been paying off US docs for years?
http://www.marketwatch.com/story/pf...ing-overseas-doctors-2012-08-07?siteid=yhoof2
Oh me, more J & J mischief,lol.
http://www.fiercepharma.com/story/j...-probes-risperdal-settlement-nears/2012-08-07
If I were a J&j shareholder I would be holding some criminal mgt feet to the fire!
Two Johnson & Johnson Subsidiaries to Pay Over $81 Million to ...www.justice.gov › Briefing RoomCached - Similar
You +1'd this publicly. Undo
Apr 29, 2010 – The government alleged that Ortho-McNeil Pharmaceutical ... as part of the settlement, Ortho-McNeil-Janssen Pharmaceuticals has agreed to ...
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million ...www.prnewswire.com/.../ortho-mcneil-janssen-pharmaceuticals-inc-a...Cached - Similar
You +1'd this publicly. Undo
Apr 29, 2010 – Ortho-McNeil-Janssen Pharmaceuticals, Inc. Agrees to $75 Million Settlement for Topamax(R) False Claims Lawsuit. Troy, Mich.-based law firm ...
Ortho-McNeil-Janssen Pharmaceuticals Inc.'s and Ortho-McNeil ...www.phillipsandcohen.com/.../Ortho-McNeil-Janssen-Pharmaceutical...Cached
You +1'd this publicly. Undo
WASHINGTON, April 29, 2010 -- One of the two whistleblower lawsuits that is being settled as part of Ortho-McNeil-Janssen Pharmaceuticals Inc.'s and ...
Criminal Investigations > May 21, 2010: Ortho-McNeil ...www.fda.gov/ICECI/CriminalInvestigations/ucm213163.htmCached - Similar
You +1'd this publicly. Undo
May 21, 2010 – Also as part of the settlement, Ortho-McNeil-Janssen Pharmaceuticals entered into a corporate integrity agreement with the Office of Inspector ...
Ortho-McNeil Settlement and Corporate Integrity Agreement - Policy ...www.policymed.com/.../ortho-mcneil-settlement-and-corporate-integ...Similar
You +1'd this publicly. Undo
May 3, 2010 – Also as part of the settlement, Ortho-McNeil-Janssen Pharmaceuticals has agreed to enter into an expansive corporate integrity agreement with ...
[PDF]
Ortho-McNeil - Gibson, Dunn & Crutcher LLPwww.gibsondunn.com/publications/Documents/orthomcneil.pdfYou +1'd this publicly. Undo
File Format: PDF/Adobe Acrobat - Quick View
The Board of Directors of Ortho-McNeil-Janssen Pharmaceuticals, inc. has authorized me £0 execute this Side Letter Agreement and the Civil Settlement ...
Teva and Ortho-McNeil-Janssen Settle Ortho Tri-Cyclen® Lo ...www.fiercebiotech.com/.../teva-and-ortho-mcneil-janssen-settle-ortho...Cached
You +1'd this publicly. Undo
Teva and Ortho-McNeil-Janssen Settle Ortho Tri-Cyclen® Lo Litigation JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) ...
Cox Announces $1.5 Million Settlement with Ortho-McNeil-Jannsenwww.michigan.gov/.../0,4534,7-164-46849_47203-241224--,00.ht...Cached
You +1'd this publicly. Undo
Jul 26, 2010 – As part of the settlement, Ortho-McNeil-Janssen has entered into a Corporate Integrity Agreement with the United States Department of Health ...
has reached - Watson Pharmaceuticals, Inc. | Investors | Press ...ir.watson.com/phoenix.zhtml?c=65778&p=irol-newsArticle...Cached
You +1'd this publicly. Undo
May 1, 2012 – Watson Reaches Settlement With Janssen Pharmaceuticals, Inc. Over ... with Janssen Pharmaceuticals, Inc. (formerly Ortho-McNeil-Janssen ...
[PDF]
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation ...www.janssenpharmaceuticalsinc.com/.../TOPAMAXPressReleaseFIN...You +1'd this publicly. Undo
File Format: PDF/Adobe Acrobat - Quick View
Apr 29, 2010 – Ortho-McNeil-Janssen Pharmaceuticals, Inc. has been cooperating with the government ... OMJPI has entered into a settlement agreement ...
GlaxoSK crooks keep on keeping on, don't they?
http://www.californiahealthline.org...settles-rx-drug-marketing-lawsuit-for-3b.aspx
Is YOUR Part D insurance company sending you drugs from outlaw countries? better check them out!
http://www.pharmalive.com/india-cracks-down-by-halting-sun-pharma-clinical-work-at-lab
Drug Dumper
Well-Known Member
- Drug Dumper Nov 12, 2013 at 10:42: AM
Drug Dumper
Well-Known Member
No, not stupid at all. I just understand the system a tad better than you do.
Oh really? YOU understand the system better than me and the rest of the World? You fit right in with the scientologists and Kevin Trudeau and his guliible readers.
You want a cure? I've got a few..
FAT people should excercise and lose weight and their diabetes is CURED!
FAT people should excercise and lose weight and their dyslipidemia is CURED!
FAT people should excercise and lose weight and their hypertension is CURED!
FAT people should excercise and lose weight and their orthopedic issues are CURED!
FAT people should excercise and lose weight and their heart disease is CURED!
FAT people should excercise and lose weight and their erectile dysfunction is CURED!
FAT people should excercise and lose weight and their thyroid problem is CURED!
FAT people should excercise and lose weight and their cancer, ulcers, gallstones, backpain, and a host of other conditions are all AVOIDED!
But of course the big bad pharma industry has cures for all of these diseases but they've all conspired together to keep them secret so they can keep treating FAT people instead of curing them....right DD you UNDERSTAND so much better.
Well, we are still all going to die.
But, you have some good points.
Drinking a lot of water and staying away from processed foods is a good thing to remember as well.